Biohaven Ltd. (BHVN) Stock Overview
Explore Biohaven Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Biohaven Ltd. (BHVN)
Key Financials
Key Financials
Market Cap
2.6B
P/E Ratio
-3.82
EPS (TTM)
$-4.64
ROE
-13.29%
BHVN Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Biohaven Ltd. (NYSE: BHVN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Biohaven Ltd.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BHVN on the NYSE shows an RSI of 68.39, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NYSE listing.
Key metrics behind Biohaven Ltd.'s NYSE-traded stock include a P/E ratio of -3.82 and a market capitalization of 2.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BHVN on the NYSE.